Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

GeoVax Labs (GOVX) Shares Outstanding (Weighted Average) (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Shares Outstanding (Weighted Average) for 16 consecutive years, with $20.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 448.13% to $20.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $20.3 million, a 448.13% increase, with the full-year FY2024 number at $5.2 million, up 185.43% from a year prior.
  • Shares Outstanding (Weighted Average) was $20.3 million for Q3 2025 at GeoVax Labs, up from $13.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $20.3 million in Q3 2025 to a low of $1.1 million in Q4 2022.
  • A 5-year average of $6.6 million and a median of $5.3 million in 2021 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): soared 2174.82% in 2021, then tumbled 87.19% in 2023.
  • GeoVax Labs' Shares Outstanding (Weighted Average) stood at $6.1 million in 2021, then crashed by 81.45% to $1.1 million in 2022, then surged by 60.6% to $1.8 million in 2023, then skyrocketed by 185.43% to $5.2 million in 2024, then skyrocketed by 291.11% to $20.3 million in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Shares Outstanding (Weighted Average) are $20.3 million (Q3 2025), $13.6 million (Q2 2025), and $12.0 million (Q1 2025).